Supplement filed pursuant to Rule 253(g)(2)
File No. 024-11058
SUPPLEMENT DATED MAY 12, 2020
TO OFFERING CIRCULAR DATED SEPTEMBER 20, 2019
NowRx, Inc.
This document supplements, and should be read in conjunction with, the Offering Circular (the “Offering Circular”) dated September 20, 2019 of NowRx, Inc. (the “Company”). Unless otherwise defined in this supplement, capitalized terms used in this supplement shall have the same meanings as set forth in the Offering Circular. The Offering Circular is available here:https://www.sec.gov/Archives/edgar/data/1702206/000114420419045501/tv529845_253g2.htm
The purpose of this supplement is to
· | Announce the Company’s intention to terminate the offering described in the Offering Circular on June 19, 2020, as qualified by reference to the description of the Company’s intentions below. |
Offering Termination Date
The Company intends to terminate the offering for its Series B Preferred Stock described in the Offering Circular. No further subscriptions will be accepted for the current offering after June 19, 2020 (the “Termination Date”). Subscriptions in the offering will be accepted up to that date and processed as promptly as possible. None of the terms of the offering have been changed. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.